MCM9 and prostate carcinoma: Copy-number variation studies in cancer genomes collated at CBioPortal30, and show that 6–7% of prostate cancers and salivary adenoid cystic carcinomas, and a smaller fraction of other cancers have homozygous deletion of MCM9 (examples listed in Table 1).